<i>Clostridium tyrobutyricum</i> in Combination with Chito-oligosaccharides Modulate Inflammation and Gut Microbiota for Inflammatory Bowel Disease Treatment-Reference-Cited by-同舟云学术

Clostridium tyrobutyricum in Combination with Chito-oligosaccharides Modulate Inflammation and Gut Microbiota for Inflammatory Bowel Disease Treatment

Published:2024-08-05 Issue:33 Volume:72 Page:18497-18506
ISSN:0021-8561
Container-title:Journal of Agricultural and Food Chemistry
language:en
Short-container-title:J. Agric. Food Chem.

Author:

Liu Zhenlei¹,Bai Pengfei²,Wang Lefei¹,Zhu Liying³,Zhu Zhengming⁴^ORCID,Jiang Ling⁴⁵^ORCID

Affiliation:

1. College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China

2. Nanjing Foreign Language School, Nanjing 210008, China

3. College of Chemical and Molecular Engineering, Nanjing Tech University, Nanjing 211816, China

4. College of Food Science and Light Industry, Nanjing Tech University, Nanjing 211816, China

5. State Key Laboratory of Materials-Oriented Chemical Engineering, Nanjing Tech University, Nanjing 211816, China

Funder

Natural Science Foundation of Jiangsu Province

Jiangsu National Synergistic Innovation Center for Advanced Materials

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jafc.4c03486

Reference43 articles.

1. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease

2. Risk of colorectal cancer in inflammatory bowel diseases

3. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease—Focusing on Intestinal Barrier Function

4. Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System

5. Treatment of IBD: Where We Are and Where We Are Going